What is Sandostatin?
Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.
Questions and answers on "Sandostatin"
Health resources related to Sandostatin
- Sandostatin for carcinoid tumors
- Is sandostatin a chemo drug
- Side effects taking sandostatin
- Does sandostatin cause insomnia
- Sandostatin dose for diarrhea
- Sandostatin in treatment varice disease
- Sandostatin lar administration
- Sandostatin lar depot side effects
- Sandostatin dosing for carcinoid
- Is hair loss a side effect of sandostatin lar depot?